SCHEMBL2013858

SCHEMBL2013858

COc1cc(C(=O)N(C)[C@H](CCNC(=O)c2cccc(C)n2)Cc2ccccc2)cc(C)n1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCRTR1 O43613 2/20 0.46
HCRTR2 O43614 2/20 0.46
OPRM1 P35372 3/20 0.40
OPRK1 P41145 2/20 0.40
HTR1A P08908 2/20 0.38
HTR2A P28223 1/20 0.38
DRD3 P35462 1/20 0.38
SIGMAR1 Q99720 3/20 0.36
TMEM97 Q5BJF2 2/20 0.36
P2RX7 Q99572 1/20 0.35
PKM P14618 1/20 0.35
KDM4E B2RXH2 1/20 0.35
LMNA P02545 1/20 0.35
HTT P42858 1/20 0.34
ALDH1A1 P00352 1/20 0.34
HPGD P15428 1/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
CTSA P10619 2/20 0.34
MMP13 P45452 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2014697 1.00 HCRTR1 (0.46) HCRTR1HCRTR2OPRM1OPRK1HTR1A
SCHEMBL2012798 0.97 HCRTR1 (0.48) HCRTR1HCRTR2OPRM1OPRK1HTR1A
SCHEMBL2013880 0.95 HCRTR1 (0.46) HCRTR1HCRTR2OPRM1OPRK1HTR1A
SCHEMBL2016502 0.90 HCRTR1 (0.49) HCRTR1HCRTR2OPRM1OPRK1HTR1A
SCHEMBL2016237 0.84 HCRTR1 (0.64) HCRTR1HCRTR2OPRM1OPRK1HTR1A
SCHEMBL2054319 0.84 HCRTR1 (0.64) HCRTR1HCRTR2OPRM1OPRK1HTR1A
SCHEMBL2014557 0.83 HCRTR1 (0.62) HCRTR1HCRTR2OPRM1OPRK1
SCHEMBL2014549 0.82 HCRTR1 (0.45) HCRTR1HCRTR2OPRM1OPRK1HTR1A
SCHEMBL2014592 0.81 HCRTR1 (0.43) HCRTR1HCRTR2OPRM1OPRK1HTR1A
SCHEMBL2051291 0.81 HCRTR1 (0.43) HCRTR1HCRTR2OPRM1OPRK1HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011073316-A1 4-ARYL-BUTANE-1,3-DIAMIDES NOVARTIS AG (CH) 2011-06-23 WO disclosed